Role of myeloid cell leukemia-1 in cell growth of squamous cell carcinoma

Journal of Pharmacological Sciences

Volumn 110, Issue 3, 2009, Pages 344-353

  Nagata, Masahide ^a   Wada, Koichiro ^a   Nakajima, Atsushi ^b   Nakajima, Noriko ^c   Kusayama, Morio ^a   Masuda, Tomotake ^a   Iida, Seiji ^a   Okura, Masaya ^a   Kogo, Mikihiko ^a   Kamisaki, Yoshinori ^a  

^a OSAKA UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Apoptosis; Human; Myeloid cell leukemia 1 (Mcl 1); Small interfering RNA (siRNA); Squamous cell carcinoma

Indexed keywords

CISPLATIN; FLUOROURACIL; FOCAL ADHESION KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PROTEIN MCL 1; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

EID: 67749143928     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08339FP     Document Type: Article

References (28)

1. Silverman S. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc. 2001;132 Suppl:7S.
2. Liang X, Lewis J, Foote R, Smith D, Kademani D. Prevalence and significance of human papillomavirus in oral tongue cancer: The Mayo Clinic Experience. J Oral Maxillofac Surg. 2008; 66:1875-1880.
3. Prince S, Bailey BM. Squamous carcinoma of the tongue: review. Br J Oral Maxillofac Surg. 1999:37:164-174.
4. Goepfert H. Squamous cell carcinoma of the head and neck: past progress and future promise. CA Cancer J Clin. 1998;48:195-198. (Pubitemid 28342606)
5. Okura M, Hiranuma T, Adachi T, Ogura T, Aikawa T, Yoshioka H, et al. Induction chemotherapy is associated with an increase in the incidence of locoregional recurrence in patients with carcinoma of the oral cavity: results from a single institution. Cancer. 1998;82:804-815. (Pubitemid 28104157)
6. Leon X, Quer M, Orus C, del Prado Venegas M, López M. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck. 2000;22:680-686.
7. Wedman J, Balm AJ, Hart AA, Loftus BM, Hilgers FJ, Gregor RT, et al. Value of resection of pulmonary metastases in head and neck cancer patients. Head Neck. 1996;18:311-316. (Pubitemid 26177704)
8. Zhou P, Qian L, Kozopas KM, Craig RW. Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood. 1997;89:630-643. (Pubitemid 27051700)
9. Goji I, Zhang B, Fenton RG. The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in multiple myeloma cells through transcriptional repression and down-regulation of Mcl-1. Clin Cancer Res. 2002;8:3527-3538. (Pubitemid 35340731)
10. Kaufmann SH, Karp JE, Letendre L, Kottke TJ, Safgren S, Greer J, et al. Phase I and pharmacologic study of infusional topotecan and Carboplatin in relapsed and refractory acute leukemia. Clin Cancer Res. 2005;11:6641-6649. (Pubitemid 41339005)
11. Craig RW. MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia. 2002;16:444-454.
12. Song L, Coppola D, Livingston S, Cress D, Haura EB. Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells. Cancer Biol Ther. 2005;4:267-276. (Pubitemid 41351285)
13. Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, Krammer PH, et al. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. BMC Cancer. 2006;6:232. (Pubitemid 44575143)
14. Masuda T, Wada K, Nakajima A, Okura M, Kudo C, Kadowaki T, et al. Critical role of peroxisome proliferator-activated receptor γ on anoikis and invasion of squamous cell carcinomas. Clin Cancer Res. 2005;11:4012-4021. (Pubitemid 40791564)
15. Urade M, Ogura T, Mima T, Matsuya T. Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity. Cancer. 1992;69:2589-2597.
16. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol. 2000;2:249-256. (Pubitemid 30781108)
17. Zhang Z, Vuori K, Reed JC, Ruoslafti E. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and upregulates Bcl-2 expression. Proc Natl Acad Sci U S A. 1995;92: 6161-6165.
18. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, et al. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol. 1995;146:1309-1319.
19. Wei LH, Kuo ML, Chen CA, Chou CH, Cheng WF, Chang MC, et al. The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene. 2001;20:5799-5809.
20. Frish SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Boil. 1994;124:619-626. (Pubitemid 24064472)
21. Chen HC, Appeddu PA, Parsons JT, Hildebrand JD, Schaller MD, Guan JL. Interaction of focal adhesion kinase with cytoskeletal protein talin. J Biol Chem. 1995;270:16995-16999.
22. Yoshida K, Hirose Y, Tanaka T, Yamada Y, Kuno T, Kohno H, et al. Inhibitory effects of troglitazone, a peroxisome proliferator- activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide. Cancer Sci. 2003;94:365-371. (Pubitemid 36626370)
23. Owens LV, Xu L, Dent GA, Yang X, Sturge GC, Craven RJ, et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol. 1996; 3:100-105. (Pubitemid 126729497)
24. Yamada KM, Geiger B. Molecular interactions in cell adhesion complexes. Curr Opin Cell Biol. 1997;9:76-85. (Pubitemid 27065112)
25. Ishida H, Wada K, Masuda T, Okura M, Kohama K, Sano Y, et al. Critical role of estrogen receptor on anoikis and invasion of squamous cell carcinoma. Cancer Sci. 2007;98:636-643. (Pubitemid 46563438)
26. Erovic BM, Pelzmann M, Grasl M, Pammer J, Kornek G, Brannath W, et al. Mcl-1, vascular endothelial growth factor-R2, and 14-3-3σ expression might predict primary response against radiotherapy and chemotherapy in patients with locally advanced squamous cell carcinomas of the head and neck. Clin Cancer Res. 2005;11:8632-8636. (Pubitemid 43005910)
27. Meyers M, Hwang A, Wagner MW, Boothman DA. Role of DNA mismatch repair in apoptotic responses to therapeutic agents. Environ Mol Mutagen. 2004;44:249-264. (Pubitemid 39447229)
28. Psyrri A, Fountzilas G. Advances in the treatment of locally advanced non-nasopharyngeal squamous cell carcinoma of the head and neck region. Med Oncol. 2006;23:1-15. (Pubitemid 43787113)